Fact CheckerSign in

NCT04645004CompletedPhase 1/2

Antenatal Platelet Response on Aspirin: a Pharmacokinetic Study Through Pregnancy

Impact of Maternal Aspirin Tehrapy on the Maternal/Fetal Unit at Delivery: a Study of Aspirin Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics Through Pregnancy

Source: ClinicalTrials.gov · Last updated 18 Apr 2024

Brief summary (registry, in English)

Longitudinal pharmacokinetic and pharmacodynamic study in first and third trimester of pregnancy

Status (registry)
Completed
Phase (registry)
Phase 1/2
Study type
Interventional
Enrollment
20 (actual)
First submitted
19 Nov 2020
Start date
29 Dec 2020
Primary completion date
11 Jan 2024
Lead sponsor
Thomas Jefferson University
NCT number
NCT04645004

What you commit to

  • Study type: Interventional · Phase 1/2
  • Participants enrolled: 20
  • From 29 Dec 2020 to the primary completion date, 11 Jan 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Use of aspirin therapy prior to enrollment in the current pregnancy

Lab values

  • Other known platelet disorder/thrombophilia at enrollment

Other

  • Contraindication to aspirin
  • Current or planned use of any other anticoagulation
  • Current need for dialysis
  • Thrombocytopenia (\<150)

Who the study is looking for

  • \<16 weeks' gestational age
  • Singleton pregnancy
  • Plan to take 81mg aspirin due to high risk history (below), but not yet initiated
  • ≥1 risk factor:
    • Chronic hypertension
    • Type I or II diabetes
    • Previous preeclampsia
    • Renal disease
    • Autoimmune disease (SLE) OR
    • ≥2 risk factor:
    • Nulliparity
    • IVF pregnancy
    • Black race or socioeconomic disadvantaged
    • BMI\>30
    • Prior adverse pregnancy outcome

Age in the registry: 13 years to 55 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Thomas Jefferson University Hospital
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.